Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Arctic Pharma: Our Latest Steps Towards Innovation
Posted on December 15th, 2016 by Claudia A. McDonald Bøen, Ph.D. in Pharma R&D
At a high level, we at Arctic Pharma are working on innovative therapies for cancer that have minimal side effects. More specifically, we are targeting certain enzymes that are up-regulated in cancer cell metabolism using inhibitors that we have designed. But the everyday reality of pursuing our goal includes small steps, many of which involve doing research or seeking potential partners outside of the lab. For instance, in the past month, we have been looking at literature searches because we are trying to put together some provisional patents that we hope we will be able to submit soon. This of course figures into our overall strategy as we work on our ultimate goal of developing and marketing anti-cancer drugs.
This month, as the year comes to a close, we will be concentrating on trying to identify a contract research organization (CRO) that would be good for us to collaborate with. We would like them to do some drug metabolism pharmacokinetics (DMPK) on our inhibitors. We are also thinking of collaborating with them to help us with the medicinal chemistry part of our project. We haven’t started doing this yet, but I know Elsevier’s solutions can tell us a little more about different CRO success stories, if there are any to share.
This is incredibly important to us as we are a lean start-up and need to pick a CRO that will help move our project forward in a timely manner. Being able to see their past work and performance history using Elsevier’s software is a huge advantage when selecting a potential collaborator. We will also be using Elsevier’s information tools to help us determine which DMPK assays we should be performing.
When you’re trying to innovate, collaboration is everything. We look forward to seeing how our collaboration with Elsevier helps us both in our scientific work and in identifying other important partnerships as we continue to advance our research efforts.
Follow The Hive to find out more.
All opinions shared in this post are the author’s own.
R&D Solutions for Pharma & Life SciencesWe're happy to discuss your needs and show you how Elsevier's Solution can help.
Claudia A. McDonald Bøen, Ph.D.
CEO at Arctic Pharma
- A Visit to Arctic Pharma in Oslo, Norway
- The Importance of Selecting The Most Promising Drug Target
- Is the Pharma Industry Missing the Big Picture?
- Getting Personal: Better Diagnosis, Better Treatment
- Cancer Immunotherapy Webinar on September 12: Register Now